Hong Fang Song - 29 Jan 2024 Form 4 Insider Report for CG Oncology, Inc. (CGON)

Role
Director
Signature
/s/ Corleen Roche, Attorney-in-Fact for Hong Fang Song
Issuer symbol
CGON
Transactions as of
29 Jan 2024
Net transactions value
+$4,999,983
Form type
4
Filing time
31 Jan 2024, 16:30:07 UTC
Previous filing
24 Jan 2024
Next filing
30 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGON Common Stock Conversion of derivative security +350,771 350,771 29 Jan 2024 Direct F1
transaction CGON Common Stock Conversion of derivative security +1,011,192 1,011,192 29 Jan 2024 By Unique Diamond Investments Limited F1, F2, F3
transaction CGON Common Stock Conversion of derivative security +3,930,176 3,930,176 29 Jan 2024 By Charming Jade Limited F1, F3, F4
transaction CGON Common Stock Purchase $4,999,983 +263,157 +75% $19.00* 613,928 29 Jan 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CGON Series B Preferred Stock Conversion of derivative security -3,344,608 -100% 0 29 Jan 2024 Common Stock 350,771 Direct F1
transaction CGON Series C Preferred Stock Conversion of derivative security -6,262,967 -100% 0 29 Jan 2024 Common Stock 656,839 By Unique Diamond Investments Limited F1, F2, F3
transaction CGON Series D Preferred Stock Conversion of derivative security -3,378,758 -100% 0 29 Jan 2024 Common Stock 354,353 By Unique Diamond Investments Limited F1, F2, F3
transaction CGON Series E Preferred Stock Conversion of derivative security -37,474,236 -100% 0 29 Jan 2024 Common Stock 3,930,176 By Charming Jade Limited F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of the Issuer's preferred stock is convertible into shares of the Issuer's common stock at the holder's election and has no expiration date. The preferred stock automatically converted into common stock upon the closing of the Issuer's initial public offering.
F2 Unique Diamond Investments Limited is a wholly owned subsidiary of ORI Healthcare Fund, L.P. ORI Capital Inc. is the general partner of ORI Healthcare Fund, L.P.
F3 Each of ORI Capital Inc. and ORI Capital II Inc. is a wholly owned subsidiary of ORI Capital Holding Inc., which is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein.
F4 Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P.